Figure 4.

Randomization of patients with poorly controlled asthma to proton pump inhibitor therapy or placebo showed no benefit of acid-suppressive therapy. The primary outcome was a decrease of 30% or more in peak expiratory flow for 2 days.

GERD, gastroesophageal reflux disease.